Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Somapacitan - Novo Nordisk

Next Previous
Drug Profile

Somapacitan - Novo Nordisk

Alternative Names: Albumin-binding somatropin - Novo Nordisk; Growth hormone derivative - Novo Nordisk; Long-acting growth hormone - Novo Nordisk; Long-acting somatropin - Novo Nordisk; NN 8640; NNC-0195-0092; Sogroya; Somatropin derivative - Novo Nordisk; Somatropin long acting - Novo Nordisk

Latest Information Update: 16 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novo Nordisk
  • Class Growth hormones; Hormonal replacements; Tetrazoles
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Somatotropin deficiency
  • New Molecular Entity No

Highest Development Phases

  • Marketed Somatotropin deficiency

Most Recent Events

  • 27 Feb 2026 Registered for Somatotropin deficiency (In adolescents, In children) in USA (SC)
  • 27 Feb 2026 Novo Nordisk expects decision form US FDA for supplemental application for Somapacitan for Turner Syndrome in 2026
  • 27 Feb 2026 Novo Nordisk submites a supplemental application for Sogroya® for Turner Syndrome in the US

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top